These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 31170922)

  • 1. Feasibility of identifying important changes in care management resulting from cardiovascular magnetic resonance (CMR) using hospital episode data in patients who activate the primary percutaneous coronary intervention (PPCI) pathway.
    Pufulete M; Harris J; Dorman S; Cook L; Bucciarelli-Ducci C; Greenwood JP; Anderson R; Brierley R; Reeves BC
    BMC Med Res Methodol; 2019 Jun; 19(1):116. PubMed ID: 31170922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developing a UK registry to investigate the role of cardiovascular magnetic resonance (CMR) in patients who activate the primary percutaneous coronary intervention (PPCI) pathway: a multicentre, feasibility study linking routinely collected electronic patient data.
    Brierley RC; Pufulete M; Harris J; Bucciarelli-Ducci C; Greenwood JP; Dorman S; Anderson R; Rogers CA; Reeves BC
    BMJ Open; 2018 Mar; 8(3):e018987. PubMed ID: 29500206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formal consensus to identify clinically important changes in management resulting from the use of cardiovascular magnetic resonance (CMR) in patients who activate the primary percutaneous coronary intervention (PPCI) pathway.
    Pufulete M; Brierley RC; Bucciarelli-Ducci C; Greenwood JP; Dorman S; Anderson RA; Harris J; McAlindon E; Rogers CA; Reeves BC
    BMJ Open; 2017 Jun; 7(6):e014627. PubMed ID: 28645959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular magnetic resonance in emergency patients with multivessel disease or unobstructed coronary arteries: a cost-effectiveness analysis in the UK.
    Stokes EA; Doble B; Pufulete M; Reeves BC; Bucciarelli-Ducci C; Dorman S; Greenwood JP; Anderson RA; Wordsworth S
    BMJ Open; 2019 Jul; 9(7):e025700. PubMed ID: 31300495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction to: Feasibility of identifying important changes in care management resulting from cardiovascular magnetic resonance (CMR) using hospital episode data in patients who activate the primary percutaneous coronary intervention (PPCI) pathway.
    Pufulete M; Harris J; Dorman S; Cook L; Bucciarelli-Ducci C; Greenwood JP; Anderson R; Brierley R; Reeves BC
    BMC Med Res Methodol; 2019 Oct; 19(1):190. PubMed ID: 31615424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and feasibility of hospital discharge 2 days following primary percutaneous intervention for ST-segment elevation myocardial infarction.
    Jones DA; Rathod KS; Howard JP; Gallagher S; Antoniou S; De Palma R; Guttmann O; Cliffe S; Colley J; Butler J; Ferguson E; Mohiddin S; Kapur A; Knight CJ; Jain AK; Rothman MT; Mathur A; Timmis AD; Smith EJ; Wragg A
    Heart; 2012 Dec; 98(23):1722-7. PubMed ID: 23053711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac magnetic resonance for asymptomatic patients with type 2 diabetes and cardiovascular high risk (CATCH): a pilot study.
    Ng MY; Zhou W; Vardhanabhuti V; Lee CH; Yu EYT; Wan EYF; Chan K; Yan AT; Ip TP; Yiu KH; Wintersperger BJ
    Cardiovasc Diabetol; 2020 Mar; 19(1):42. PubMed ID: 32234045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple biomarkers at admission are associated with angiographic, electrocardiographic, and imaging cardiovascular mechanistic markers of outcomes in patients undergoing primary percutaneous coronary intervention for acute ST-elevation myocardial infarction.
    Damman P; Kuijt WJ; Woudstra P; Haeck JD; Koch KT; Gu YL; van Straalen JP; Fischer J; Tijssen JG; Krucoff MW; de Winter RJ
    Am Heart J; 2012 May; 163(5):783-9. PubMed ID: 22607855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical associations of microvascular obstruction and intramyocardial hemorrhage on cardiovascular magnetic resonance in patients with acute ST segment elevation myocardial infarction (STEMI): An observational cohort study.
    Ma M; Diao KY; Yang ZG; Zhu Y; Guo YK; Yang MX; Zhang Y; He Y
    Medicine (Baltimore); 2018 Jul; 97(30):e11617. PubMed ID: 30045300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of transaminases after acute ST-elevation myocardial infarction: insights from a cardiac magnetic resonance study.
    Reinstadler SJ; Reindl M; Feistritzer HJ; Klug G; Mayr A; Kofler M; Tu AM; Huybrechts L; Mair J; Franz WM; Metzler B
    Wien Klin Wochenschr; 2015 Nov; 127(21-22):843-850. PubMed ID: 26443690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing Cardiac Magnetic Resonance-Guided Versus Angiography-Guided Treatment of Patients With Stable Coronary Artery Disease: Results From a Prospective Randomized Controlled Trial.
    Buckert D; Witzel S; Steinacker JM; Rottbauer W; Bernhardt P
    JACC Cardiovasc Imaging; 2018 Jul; 11(7):987-996. PubMed ID: 29976305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of arterial access site selection on outcomes in primary percutaneous coronary intervention: are the results of randomized trials achievable in clinical practice?
    Mamas MA; Ratib K; Routledge H; Neyses L; Fraser DG; de Belder M; Ludman PF; Nolan J;
    JACC Cardiovasc Interv; 2013 Jul; 6(7):698-706. PubMed ID: 23769648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Stratification of Patients With ST-Segment-Elevation Myocardial Infarction (PROSPECT): A Cardiac Magnetic Resonance Study.
    Pontone G; Guaricci AI; Andreini D; Ferro G; Guglielmo M; Baggiano A; Fusini L; Muscogiuri G; Lorenzoni V; Mushtaq S; Conte E; Annoni A; Formenti A; Mancini ME; Carità P; Verdecchia M; Pica S; Fazzari F; Cosentino N; Marenzi G; Rabbat MG; Agostoni P; Bartorelli AL; Pepi M; Masci PG
    Circ Cardiovasc Imaging; 2017 Nov; 10(11):. PubMed ID: 29146587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The sum of ST-segment elevation is the best predictor of microvascular obstruction in patients treated successfully by primary percutaneous coronary intervention. Cardiovascular magnetic resonance study.
    Husser O; Bodí V; Sanchis J; Núnez J; Mainar L; Rumiz E; López-Lereu MP; Monmeneu J; Chaustre F; Trapero I; Forteza MJ; Riegger GA; Chorro FJ; Llàcer A
    Rev Esp Cardiol; 2010 Oct; 63(10):1145-54. PubMed ID: 20875354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and prognostic value of regadenoson stress cardiovascular magnetic resonance imaging in heart transplant recipients.
    Kazmirczak F; Nijjar PS; Zhang L; Hughes A; Chen KA; Okasha O; Martin CM; Akçakaya M; Farzaneh-Far A; Shenoy C
    J Cardiovasc Magn Reson; 2019 Jan; 21(1):9. PubMed ID: 30674318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance and relationship of worst lead residual ST segment elevation with myocardial damage assessed by cardiovascular MRI in myocardial infarction.
    Rommel KP; Baum A; Mende M; Desch S; Gutberlet M; Schuler G; Thiele H; Eitel I
    Heart; 2014 Aug; 100(16):1257-63. PubMed ID: 25049315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variation in cardiovascular disease care: an Australian cohort study on sex differences in receipt of coronary procedures.
    Fogg AJ; Welsh J; Banks E; Abhayaratna W; Korda RJ
    BMJ Open; 2019 Jul; 9(7):e026507. PubMed ID: 31337660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac troponin elevation pattern in patients undergoing a primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: characterization and relationship with cardiovascular events during hospitalization.
    Buber J; Laish-Farkash A; Koren-Morag N; Fefer P; Segev A; Hod H; Matetzky S
    Coron Artery Dis; 2015 Sep; 26(6):503-9. PubMed ID: 26061436
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.